Results 121 to 130 of about 14,191,855 (253)

Phase‐Change and Ovonic Materials (Second Edition) [PDF]

open access: yesphysica status solidi (RRL) – Rapid Research Letters, 2021
Noé, Pierre   +2 more
openaire   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Design of Multifunctional Polarization Waveplates Based on Thermal Phase-Change Metasurfaces

open access: yesCrystals
The switching function of traditional waveplates necessitates mechanical replacement or the superimposition of multiple waveplates, which gives rise to a complex system and a large volume.
Bo Cheng   +6 more
doaj   +1 more source

New hydrogen storage/phase change materials and their thermochemistry studies

open access: yes, 2012
New hydrogen storage phase change materials and their thermochemistry ...
孙立贤
core  

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Reconfigurable image processing metasurfaces with phase-change materials

open access: yesNature Communications
Optical metasurfaces have enabled analog computing and image processing within sub-wavelength footprints, and with reduced power consumption and faster speeds.
Michele Cotrufo   +6 more
doaj   +1 more source

Carbon nanotube-Cu foam hybrid reinforcements in composite phase change materials with enhanced thermal conductivity

open access: yes, 2019
Carbon nanotube-Cu foam hybrid reinforcements in composite phase change materials with enhanced thermal ...
Hu, Naixiu   +9 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy